Pacific Heights Asset Management LLC Buys 18,000 Shares of Agilent Technologies, Inc. $A

Pacific Heights Asset Management LLC increased its position in Agilent Technologies, Inc. (NYSE:A) by 17.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,000 shares of the medical research company’s stock after acquiring an additional 18,000 shares during the quarter. Pacific Heights Asset Management LLC’s holdings in Agilent Technologies were worth $15,402,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Forum Financial Management LP increased its stake in shares of Agilent Technologies by 2.5% in the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after purchasing an additional 70 shares in the last quarter. Wedmont Private Capital lifted its stake in shares of Agilent Technologies by 2.3% during the 3rd quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock valued at $503,000 after buying an additional 81 shares in the last quarter. waypoint wealth counsel boosted its holdings in Agilent Technologies by 4.3% in the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock worth $255,000 after buying an additional 82 shares during the period. Verdence Capital Advisors LLC increased its stake in Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock worth $215,000 after buying an additional 86 shares in the last quarter. Finally, M&T Bank Corp increased its stake in Agilent Technologies by 0.4% in the 2nd quarter. M&T Bank Corp now owns 23,205 shares of the medical research company’s stock worth $2,738,000 after buying an additional 86 shares in the last quarter.

Insider Activity

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president directly owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Padraig Mcdonnell sold 911 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer directly owned 32,058 shares of the company’s stock, valued at $4,591,987.92. The trade was a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 16,401 shares of company stock worth $2,468,962 over the last 90 days.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Robert W. Baird upped their price objective on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 25th. Morgan Stanley initiated coverage on Agilent Technologies in a report on Tuesday, December 2nd. They issued an “overweight” rating on the stock. UBS Group upped their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. TD Cowen lifted their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Finally, Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Agilent Technologies Stock Down 3.6%

Shares of A opened at $139.68 on Tuesday. The stock has a market capitalization of $39.60 billion, a price-to-earnings ratio of 30.56, a price-to-earnings-growth ratio of 4.05 and a beta of 1.29. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The business’s 50 day simple moving average is $144.27 and its 200-day simple moving average is $133.67. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. During the same period last year, the firm posted $1.46 earnings per share. Agilent Technologies’s revenue for the quarter was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a $0.255 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is presently 22.32%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.